Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04535934 · ClinicalTrials.gov registry record
Novel Approaches for Quantitative Assessment of Adherence
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 15
- Enrollment target
NCT04535934: Completed study, sponsored by University of Colorado, Denver.
NCT04535934 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04535934 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Approximately 12 adults subjects will be enrolled. Participants will be randomized to one of two directly observed dosing regimens with 2mg adenine 5+ (five stable-labeled nitrogens) as follows: 1 dose/week followed by 4 doses/week OR 3 doses/week followed by 7 doses/week. Each dose regimen will have a duration of approximately 12 weeks and will be separated by a 12-week washout period for a total study duration of approximately 36 weeks. Dried blood spots (DBS) and whole blood will be collect weekly. Urine will be collected less frequently, about every 2 weeks. The ratio of ATP 5+ to naturally occurring ATP 2+ is dried blood spots will be the primary outcome, as adenine is phosphorylated to ATP in red blood cells. Breakdown products will be measured in urine. Investigators will allow flexibility in terms of which days are used for dosing for the 1, 3, and 4 dose(s)/week regimens. This is scientifically justified as investigators expect a 20-30 day half-life of ATP 5+ in DBS.
Primary Outcome
Ratio of ATP 5+ to ATP 2+ in DBS following directly observed therapy with 2mg of adenine 5+ at 1, 3, 4, and 7 doses/week
Interventions
- OTHER Adenine 5+ (five stable-labeled nitrogens)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2022-11-15 |
What the finished NCT04535934 record still lists
NCT04535934 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Adenine 5+ (five stable-labeled nitrogens) is the first listed.
NCT04535934 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04535934 about?
NCT04535934 is a clinical study titled "Novel Approaches for Quantitative Assessment of Adherence". Approximately 12 adults subjects will be enrolled. Participants will be randomized to one of two directly observed dosing regimens with 2mg adenine 5+ (five stable-labeled nitrogens) as follows: 1 dose/week followed by 4 doses/week OR 3 doses/week followed by 7 doses/week. Each dose regimen will hav...
What is the current status of trial NCT04535934?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2020-08-31. Estimated completion is 2022-11-15.
What interventions are being tested in trial NCT04535934?
The interventions under investigation include: Adenine 5+ (five stable-labeled nitrogens) (OTHER).
Who is sponsoring clinical trial NCT04535934?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI